deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02378038

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

A Phase II Study of PNT2258 in Patients With Richter's Transformation (RT)

Sponsor: Sierra Oncology LLC - a GSK company

Conditions Richter's Transformation
Interventions PNT2258
Updated 11 times since 2017 Last updated: Jun 14, 2023 Started: Aug 31, 2015 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Sierra Oncology LLC - a GSK company

See all terminations from Sierra Oncology LLC - a GSK company

Other Richter's Transformation trials with similar outcome

Browse all Richter's Transformation trials

A PHASE2 clinical study on Richter's Transformation, this trial is terminated or withdrawn. The trial is conducted by Sierra Oncology LLC - a GSK company and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Apr 2020 · 22 months · monthly snapshotTerminated~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2023 · 6 months · monthly snapshotTerminated~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jul 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jan 2023 — Jul 2023 [monthly]

    Terminated PHASE2

  5. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

▶ Show 6 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE2

  2. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2

  3. Apr 2020 — Jan 2021 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Apr 2020 [monthly]

    Terminated PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sierra Oncology LLC - a GSK company
Data source: Sierra Oncology LLC - a GSK company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations